期刊文献+

利用ESI-Q-TOF-MS/MS区分人参皂苷Rh2和CK 被引量:4

Differentiation of Ginsenoside Isomers Rh_2 and CK Using ESI-Q-TOF-MS/MS
下载PDF
导出
摘要 为了建立快速、准确地区分人参皂苷同分异构体Rh2和CK的分析方法,利用电喷雾-四极杆-飞行时间串联质谱(ESI-Q-TOF-MS/MS)技术,分别在正离子、负离子模式下采用不同的碰撞能量对人参皂苷同分异构体Rh2和CK进行MS/MS研究。结果表明:在负离子模式下,二者均产生相同的特征碎片离子;但在相同的碰撞能量下,Rh2的特征碎裂离子丰度明显低于CK的碎裂离子丰度。在正离子模式下,二者的裂解规律有明显的差异;CK在碰撞能量为20、40、60eV时,出现特征碎片离子m/z465和m/z203;而Rh2则仅在较高碰撞能量60eV时,产生该特征碎片离子。通过比较Rh2和CK的MS/MS裂解规律,能够快速区分这两个同分异构体。 A rapid analysis method of electrospray-quadrupole-time-of-flight mass spectrometry (ESI-Q-TOF-MS/MS) was established to differentiate ginsenoside isomers Rh2 and compound K (CK).Based on the analysis of MS/MS product ions with different collision energy in both negative and positive ion mode,ginsenoside isomers Rh2 and CK are distinguished.The results show that the fragmentation pathway of Rh2 and CK in negative ion mode is similar.The difference is that the fragment ion abundance of Rh2 is significantly lower than that of CK with the same collision energy.The fragmentation behavior of Rh2 is different from CK in positive ion mode,specific fragment ions m/z 465 and m/z 203 are produced with collision energy 20,40 and 60 eV in CK,but Rh2 produces the similar specific fragment ions only with collision energy 60 eV in MS/MS.The MS/MS fragmentation pathway is particularly useful in the identification of ginsenoside isomers Rh2 and CK.
出处 《质谱学报》 EI CAS CSCD 北大核心 2014年第2期158-162,共5页 Journal of Chinese Mass Spectrometry Society
基金 吉林省科技发展重大项目(20096043) 吉林省高校创新团队发展计划项目(JTD201213)资助
关键词 电喷雾-四极杆-飞行时间串联质谱(ESI-Q-TOF-MS MS) 人参皂苷 同分异构体 electrospray-quadrupole-time-of-flight mass spectrometry (ESI-Q-TOF-MS/MS) ginsenoside isomer
  • 相关文献

参考文献23

  • 1ATTELE A S,WU J A,YUAN C S.Ginseng pharmacology:Multiple constituents and multiple actions[J].Biochemical Pharmacology,1999,58(11):1 685-1 693.
  • 2CHRISTENSEN L P.Ginsenosides:Chemistry,biosynthesis,analysis,and potential health effects[J].Advances in Food and Nutrition Research,2008,55:1-99.
  • 3程慧,宋新波,张丽娟.人参皂苷Rg3与Rh2的研究进展[J].药物评价研究,2010,33(4):307-311. 被引量:57
  • 4MUSENDE A G,EBERDING A,WOOD C,et al.Preclinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo:Formulation,pharmacokinetics,biodistribution and efficacy[J].Cancer Chemother Pharmacol,2009,64(60):1 085-1 095.
  • 5于雷,李成龙,于珊珊.人参皂苷CK的研究进展[J].生物技术通报,2013,29(1):31-35. 被引量:13
  • 6CHAE S,KANG K A,CHANG W Y,et al.Effect of compound K,a metabolite of ginseng saponin,combined with gamma-ray radiation in human lung cancer cells in vitro and in vivo[J].J Agric Food Chem,2009,57(13):5 777-5 782.
  • 7杨金玲,高丽丽,朱平.人参皂苷生物合成研究进展[J].药学学报,2013,48(2):170-178. 被引量:68
  • 8CHO S H,CHUNG K S,CHOI J H,et al.Compound K,a metabolite of ginseng saponin,induces apoptosis via caspase-8-dependent pathway in HL60 human leukemia cells[J].BMC Cancer,2009,9(1):449 461.
  • 9杨元超,王英平,闫梅霞,孙成贺,郑培和.人参皂苷compound K转化菌株的筛选[J].中国中药杂志,2011,36(12):1596-1598. 被引量:16
  • 10赵立亚,鱼红闪,金凤燮.酶法生产稀有人参皂甙及其产物成分的分析[J].大连轻工学院学报,2002,21(2):112-115.

二级参考文献100

共引文献193

同被引文献75

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部